NCT03712124 - A Study of CNSA-001 in Women With Diabetic Gastroparesis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

September 8, 2019

Study Completion Date

October 8, 2019

Conditions

Gastroparesis

Interventions

DRUG

CNSA-001

CNSA-001 Powder for Suspension

DRUG

Placebo

Placebo Suspension

Trial Locations (6)

Johns Hopkins University, Baltimore

LMG Research, Miami

Clinical Research Solutions, LLC, Jackson

University of Louisville, Louisville

Indiana University Hospital, Indianapolis

GW Research, Inc., Chula Vista